Century Therapeutics updates investor presentation focused on T1D pipeline; no specific new data disclosed

Century Therapeutics, Inc.

Filed updated slide presentation under Item 7.01 used in investor meetings, dated January 12, 2026.
Presentation titled 'Unlocking the Value of our Pipeline for T1D' signals strategic focus on type 1 diabetes.
Available text contains only cover slide and forward-looking statements; no new clinical or financial details visible.
No changes to guidance, pipeline milestones, or financial outlook were provided in the filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.